Summary & Overview
CPT 0916T: Implantation of Permanent Pulse Generator for CCM‑DF System
CPT code 0916T covers implantation of a permanent pulse generator for a cardiac contractility modulation–defibrillation (CCM‑DF) system, including fluoroscopic placement as needed and device evaluation and programming. This code represents an advanced implantable cardiac device service used in managing select patients with heart failure and arrhythmic risk, and it is relevant to hospitals, electrophysiology practices, and payers evaluating coverage for novel device therapies. Nationally, CPT code 0916T captures a specialized procedural category tied to device-based heart failure management and defibrillation capability.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the procedure, expected sites of service, and the common payer landscape. The publication summarizes typical billing considerations, commonly applied modifiers, and the clinical workflow elements involved in implantation, programming, and post‑implant evaluation. It also outlines which types of stakeholders—electrophysiologists, cardiac surgeons, device clinics, and hospital billing teams—are most likely to engage with this code. Data not available in the input are noted where applicable.
Billing Code Overview
CPT code 0916T describes the implantation of a permanent pulse generator for a cardiac contractility modulation–defibrillation (CCM‑DF) system. The procedure includes placement of the pulse generator, which may use fluoroscopic guidance, and evaluation and programming of the device to confirm proper function.
-
Service type: Implantation of an implantable cardiac device (permanent pulse generator placement for CCM‑DF system)
-
Typical site of service: Inpatient or outpatient surgical setting where implantable cardiac devices are placed; commonly performed in electrophysiology laboratories or cardiac catheterization suites with fluoroscopic capability.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with symptomatic heart failure and reduced ejection fraction, frequent hospitalizations for congestion, and persistent symptoms despite guideline-directed medical therapy is evaluated by a heart failure cardiologist. The multidisciplinary team determines the patient is a candidate for implantation of a combined cardiac contractility modulation–defibrillation system to provide contractility modulation plus defibrillation protection. Pre-procedure workflow includes informed consent, pre-operative evaluation (history, focused exam, anticoagulation management), device selection and programming plan, and baseline device interrogation. The procedure is performed in a cardiac electrophysiology laboratory under conscious sedation or general anesthesia with continuous hemodynamic and rhythm monitoring. Fluoroscopic guidance is used to place the pulse generator and leads; intraoperative testing confirms lead position and defibrillation thresholds as appropriate. The device is evaluated and programmed intraoperatively to ensure correct conduction of contractility modulation signals and defibrillation function. Post-procedure care includes device interrogation, wound care, telemetry monitoring, discharge instructions, and scheduled outpatient follow-up for programming optimization and heart-failure management.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when operative complexity or time is substantially greater than usual for implantation due to anatomy or comorbidities. |
23 | Unusual anesthesia | Use when general anesthesia is medically necessary for reasons unrelated to the procedure complexity. |
51 | Multiple procedures | Use when this implantation is billed alongside other distinct surgical procedures the same day. |
52 | Reduced services | Use when the procedure is partially reduced or not completed as planned. |
53 | Discontinued procedure | Use when the procedure is started but terminated due to an extenuating circumstance. |
62 | Two surgeons | Use when two surgeons work together as primary surgeons for portions of the procedure. |
66 | Surgical team | Use when a surgical team approach is required for billing. |
78 | Unplanned return to OR following initial procedure | Use for a return to the operating room for a related procedure during the global period. |
80 | Assistant surgeon | Use when an assistant surgeon is documented and qualifies for payment. |
81 | Minimum assistant surgeon | Use when minimal assistant involvement is documented. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207RH0000X | Cardiology | Electrophysiologists and interventional cardiologists who perform device implantations. |
| 207RP1001X | Cardiac Electrophysiology | Physicians specialized in device implantation and programming. |
| 208D00000X | Thoracic Cardiac Surgery | Cardiac surgeons who may participate in complex device implants or revisions. |
| 171V00000X | Pulmonary Disease (Heart Failure Management teams) | Heart failure specialists participating in candidate selection and follow-up. |
| 363L00000X | Nurse Practitioner | Advanced practice providers involved in device follow-up and interrogation. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
I50.22 | Chronic systolic (congestive) heart failure | Common indication for contractility modulation therapy to improve contractile function. |
I50.32 | Chronic diastolic (congestive) heart failure | May coexist with systolic dysfunction and influence device candidacy and programming. |
I50.9 | Heart failure, unspecified | Used when specific heart failure type is not documented but device therapy is provided for symptomatic heart failure. |
I42.0 | Dilated cardiomyopathy | Structural cardiomyopathy often associated with reduced ejection fraction and device consideration. |
I25.10 | Atherosclerotic heart disease of native coronary artery without angina pectoris | Common comorbidity in patients with ischemic cardiomyopathy considered for device therapy. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
33249 | Insertion or replacement of automatic implantable cardioverter-defibrillator, with transvenous lead(s), single or dual chamber | Alternative or complementary defibrillator implantation when separate ICD therapy is required; may be performed instead of or in conjunction with contractility device components. |
33233 | Insertion of new or replacement of pacemaker generator only, single lead system; without lead placement or revision | Used when only generator replacement is performed or when pacemaker therapy is combined or compared in device strategies. |
33224 | Insertion of new or replacement of dual lead pacemaker, single or dual chamber system (transvenous) | Relevant when additional pacing leads are required or when pacing components are part of the procedural plan. |
93279 | Programming device evaluation and management, complex device systems | Used for intraoperative or post-implant detailed programming and interrogation beyond standard device checks. |
93306 | Echocardiography, transthoracic, real-time with image documentation, during interventional procedures when used for guidance | May be used intra- or post-procedurally to assess cardiac function and guide lead placement if performed. |
76000 | Fluoroscopy (radiographic) of extremity, any method | Represents fluoroscopic guidance modality used during lead and generator placement; facility billing may use appropriate fluoroscopy codes when applicable. |